Unlike in the rest of the country, where intestinal ultrasound rarely is used in the clinic, in New York City, gastroenterologists at Mount Sinai Hospital have made IUS findings the “the fifth vital sign” for inflammatory bowel disease patient care, particularly to monitor disease. Now, new research from the institution and other centers is showing that the tool can identify patients with endoscopic recurrence and possibly predict disease outcomes and treatment response.
Trending
- With AI and biomarkers, selfies could support doctors’ decision-making (Healthcare IT News)
- AI-Based Ambient Scribes May Reduce Physician Documentation Time, Burnout (Gastroenterology Advisor)
- ChatGPT’s AI Health-Care Push Has a Fatal Flaw (Bloomberg)
- Exploring trust factors in AI-healthcare integration: a rapid review (Frontiers in Artficial Intelligence)
- ChatGPT’s AI Health-Care Push Has a Fatal Flaw (Bloomberg)
- AI is speeding into healthcare. Who should regulate it? (The Harvard Gazette)
- Ethical and Legal Considerations for Responsible Use of AI in Clinical Gastroenterology (American Journal of Gastroenterology)
- Google Launches MedGemma 1.5 & MedASR to Broaden Healthcare AI Capabilities (Digital Health News)
